2014

Kewaunee Scientific Reports Improved Sales and Earnings for First Quarter

STATESVILLE, N.C., Aug. 21, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2012.

Net earnings for the quarter were $634,000, or $0.25 per diluted share, up from net earnings of $22,000, or $0.01 per diluted share, in the first quarter of the prior year. Earnings for the quarter were favorably impacted by lower operating costs resulting from cost savings initiatives commenced in the second half of the prior year and the Company's strategy to move toward a more profitable product sales mix.  Sales for the quarter were $26,683,000, up 1.4% from sales of $26,321,000 in the first quarter last year.

Domestic sales were $22,629,000, down 3.3% from sales of $23,396,000 in the prior year period. The lower domestic sales dollars were expected as part of a strategy underway by the Company to sell more laboratory projects through its strengthened and expanded dealer network. This is resulting in increased sales of manufactured products, but lower overall sales, as the dealers provide the related project management, installation, and other service activities, which are typically less profitable for the Company. Regarding the laboratory marketplace, opportunities for privately funded projects continue to hold up relatively well, although at extremely competitive prices, while opportunities for publicly funded educational projects remain well below pre-recession levels.

International sales were $4,054,000, up 38.6% from $2,925,000 in the prior year period. The Company continues to make changes to strengthen and expand its international dealer network to better position the Company to take advantage of increased sales opportunities in the fast growing research markets of Asia and the Middle East.

The order backlog increased to a record $86.7 million at July 31, 2012, up from $86.2 million at April 30, 2012 and $69.7 million at July 31, 2011.

The Company's balance sheet continues to be strong. Cash on hand was $8.4 million at the end of the quarter, as compared to $3.6 million at the end of the first quarter last year.  Working capital was $24.0 million, as compared to $22.1 million at the end of the first quarter last year. Short-term borrowings under the Company's $15 million bank line of credit were $6.5 million, as compared to $8.7 million at the end of the first quarter last year. Total bank borrowings and capital lease obligations were $10.1 million, as compared to $12.6 million at the end of the first quarter last year, and the debt-to-equity ratio was .34-to-1, as compared to .40-to-1 at the end of the first quarter last year.

"We are pleased with our continuing progress," said William A. Shumaker, Kewaunee's Chief Executive Officer.  "Sales and earnings are benefiting from our strengthened and expanded dealer network, new innovative products being introduced to the marketplace, and lower manufacturing and overhead costs. Additionally, earnings and profit margins are benefiting from an improved product mix related to our strategy to sell more laboratory projects through our dealer network.

"Looking forward, I expect sales and earnings for fiscal year 2013 to be much improved over fiscal year 2012. Our strengthened dealer organization, both domestically and internationally, is providing us increased opportunities for sales and orders, while our lower operating costs are improving profit margins and making us more competitive in the marketplace."

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin counters and sinks. Healthcare furniture products include laminate casework, storage systems, and related products for healthcare applications. Technical furniture products include column systems, slotted-post systems, pedestal systems, and stand-alone benches.

The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets.  One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.                              

 

Consolidated Statements of Operations [unaudited]


(in thousands, except per share data)







Three Months Ended


 July 31


 July 31


2012


2011





     Net sales                                             

$26,683


$26,321

     Cost of products sold                            

21,440


22,133





     Gross profit                                         

5,243


4,188

     Operating expenses                               

4,138


3,955





     Operating earnings                              

1,105


233

     Other income (expense)                           

68


(1)





     Interest expense                                       

(114)


(95)





     Earnings before income taxes                

1,059


137

     Income tax expense                                   

371


29





     Net earnings                                               

688


108

     Less: net earnings attributable to




        the noncontrolling interest                       

54


86





     Net earnings attributable to




         Kewaunee Scientific Corporation      

$634


$22





     Net earnings per share attributable to




         Kewaunee Scientific Corporation stockholders




           Basic                                           

$0.25


$0.01

           Diluted                                          

$0.25


$0.01





     Weighted average number of common




       shares outstanding




           Basic                                             

2,581


2,579

           Diluted                                            

2,584


2,580

                                                                  

Condensed Consolidated Balance Sheets


(in thousands)







July 31


 April 30


2012


2012


[unaudited]



Assets




Cash and cash equivalents                                                      

$7,720


$6,188

Restricted cash                                                                            

653


704

Receivables, less allowances                                                       

22,542


23,244

Inventories                                                                                  

11,717


11,760

Prepaid expenses and other current assets                                   

2,217


1,702

   Total Current Assets                                                                

44,849


43,598

Net property, plant and equipment                                              

15,122


15,346

Other assets                                                                            

5,219


5,192

Total Assets                                                                             

$65,190


$64,136



Liabilities and Equity


Short-term borrowings                                                                

$6,501


$6,816

Current obligations under capital leases                                        

15


36

Current portion of long-term debt                                                   

200


200

Accounts payable                                                                        

8,769


8,848

Other current liabilities                                                               

5,327


4.340

   Total Current Liabilities                                                        

20,812


20,240

Other non-current liabilities                                                        

12,411


12,238

   Total Liabilities                                                                       

33,223


32,478

Noncontrolling interest                                                                

2,132


2,147

Kewaunee Scientific Corporation equity                                   

29,835


29,511

   Total Equity                                                                        

31,967


31,658

Total Liabilities and Equity                                                      

$65,190


$64,136

 

Contact: D. Michael Parker
704/871-3290

 

SOURCE Kewaunee Scientific Corporation



RELATED LINKS
http://www.kewaunee.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.